Private Equity Investor PLCPress Releases
About the Fund
Our Portfolio
Company Personnel
Annual Report
Interim Report
Regulatory News
General Meetings
Press Releases
Articles of Association
Share Price
Home
4th Floor, 23 Bentinck Street, London W1U 2EZ - Tel +44 (0)20 7563 1630 - Fax +44 (0)20 7486 4534
Net Asset Value 228.06p/341.20¢ inc. current period deficit; 228.73p/342.20¢ exc. current period deficit
per ordinary share at 30 June 2010 incorporating unaudited Revenue Reserves to 31 May 2010 (exchange rate, £1=US$1.4961).
For Limited Partnerships Revaluations see Our Portfolio.
Registered office
Beaufort House
51 New North Road
Exeter, EX4 4EP
Company Number
3912487 – England & Wales


HACKER SAFE certified sites prevent over 99.9% of hacker crime.
Connector
Opening the doors to world class opportunity at the venture stage
Linking IT investment in the UK and USA

25 JUNE 2002

Private Equity Investor PLC appoints new director

Private Equity Investor PLC, the investment trust which invests principally in early to pre-IPO stage information technology companies, has appointed Peter Dicks as a non-executive Director.

Peter has over 30 years of experience in the private equity sector and co-founded Abingworth, one of the UK's first venture capital companies, in 1973 where he stayed until 1991. The majority of Abingworth's portfolio consisted of American technology companies and it was an early investor in, amongst others, Apple, Silicon Graphics and 3COM. Since then, he has been non-executive Director or Chairman of a number of companies in the private equity or investment field including Vencap International Fund Managers Ltd, Gartmore Fledgling Trust PLC and Sportingbet PLC.

Tim Childs, Managing Director of Private Equity Investor, said: "Peter's decision to join the Board is a great endorsement for Private Equity Investor and its investment strategy."


Enquiries
Tim Childs, Managing Director, Private Equity Investor PLC, Tel: 020 7930 5600
John West/Rosie Brown, Tavistock Communications, Tel: 020 7600 2288


Notes to editors
The Company seeks to achieve substantial capital appreciation by investing in emerging growth companies through specialised US venture capital funds focused on the information technology, biotechnology and healthcare sectors.


Return to Press Release Index